|
| Read more ›› |
|
By: GlobenewsWire - 15 Jun 2022
|
|
Related companies:
Sernova Corp |
Sinovac Biotech Ltd. |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 15 Jun 2022
|
|
Related companies:
AnchorDx Medical Co., Ltd. |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 15 Jun 2022
|
|
Related companies:
Beijing Genomics Institute (BGI) |
BGI Europe A/S |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 15 Jun 2022
|
|
Related companies:
Shenzhen Mindray Bio-Medical Electronics Co.,Ltd. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 14 Jun 2022
|
|
Related companies:
Sichuan Clover Biopharmaceuticals, Inc. |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 14 Jun 2022
|
|
Related companies:
Alphamab Oncology |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 14 Jun 2022
|
|
Related companies:
Suzhou Kintor Pharmaceuticals, Inc. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 14 Jun 2022
|
|
Related companies:
Sichuan Clover Biopharmaceuticals, Inc. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 13 Jun 2022
|
|
Related companies:
Mustang Investment Consulting (Shanghai) Co., Ltd. |
Mustang Bio |
|
|
| Read more ›› |
|
By: GlobenewsWire - 13 Jun 2022
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 13 Jun 2022
|
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 13 Jun 2022
|
|
Related companies:
Ascletis Pharma Inc. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 12 Jun 2022
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 10 Jun 2022
|
|
Related companies:
Anpac Technology USA (Anpac Bio) |
AnPac Bio-Medical Science Co., Ltd. |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 10 Jun 2022
|
|
Related companies:
Keymed Biosciences Inc. |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 10 Jun 2022
|
|
Related companies:
Everest Medicines (Shanghai) |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 08 Jun 2022
|
|
Related companies:
Ascletis Pharma Inc. |
|
|
| The STAMINA-001 study will evaluate the safety, pharmacology and preliminary efficacy of ATG-037 as a monotherapy or in combination with pembrolizumab, an immune checkpoint inhibitors (ICIs), in patients with locally advanced or metastatic solid tumors;ATG-037 is an orally-available, small molecule... Read more ›› |
|
By: PR Newswire Association LLC. - 08 Jun 2022
|
|
Related companies:
Antengene Corporation |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 08 Jun 2022
|
|
Related companies:
Ascentage Pharma Group International |
|
|
| Read more ›› |
|
By: GlobenewsWire - 07 Jun 2022
|
|
Related companies:
Sichuan Clover Biopharmaceuticals, Inc. |
|
|
|
|
|
Biotechgate Global Database ›
